Is innate immunity our best weapon for flattening the curve?
Open Access
- 3 August 2020
- journal article
- editorial
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 130 (8), 3954-3956
- https://doi.org/10.1172/jci140530
Abstract
Broadly activating innate immunity, which has been achieved via unrelated vaccines or Type-I INF-like factors, may effectively treat or prevent COVID-19 and future coronavirus diseases.This publication has 24 references indexed in Scilit:
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathologySeminars in Immunopathology, 2017
- Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic reviewBMJ, 2016
- Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancerBritish Journal of Cancer, 2016
- Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected MiceCell Host & Microbe, 2016
- To sense or not to sense viral RNA—essentials of coronavirus innate immune evasionCurrent Opinion in Microbiology, 2014
- Control of Human Viral Infections by Natural Killer CellsAnnual Review of Immunology, 2013
- Development of a Nucleocapsid-Based Human Coronavirus Immunoassay and Estimates of Individuals Exposed to Coronavirus in a U.S. Metropolitan PopulationClinical and Vaccine Immunology, 2008
- Natural History of a Recurrent Feline Coronavirus Infection and the Role of Cellular Immunity in Survival and DiseaseJournal of Virology, 2005
- Ancillary Therapy of Bovine Respiratory DiseaseVeterinary Clinics of North America: Food Animal Practice, 1997
- The time course of the immune response to experimental coronavirus infection of manEpidemiology and Infection, 1990